Ghazi Kashmolah - 16 Feb 2023 Form 4 Insider Report for Lucira Health, Inc.

Role
Ex VP & Chief Quality Officer
Signature
/s/ Richard Narido, Attorney-in-Fact for Ghazi Kashmolah
Issuer symbol
N/A
Transactions as of
16 Feb 2023
Net transactions value
-$1,358
Form type
4
Filing time
21 Feb 2023, 11:38:45 UTC
Previous filing
09 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LHDXQ Common Stock Sale $1,358 -5,028 -3.6% $0.2700* 134,075 16 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ghazi Kashmolah is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on September 30,2021 for 197,240 shares.